期刊文献+

STAT3与SOCS3在乳腺癌组织中的表达及生物学行为相关性分析 被引量:2

Expressions of signal transducer and activators of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) proteins in breast carcinoma and their association with biological behaviors
下载PDF
导出
摘要 目的:研究乳腺癌组织中信号转导和转录激活因子3(STAT3)和细胞因子信号转导抑制分子3(SOCS3)的表达与肿瘤分化、浸润、转移的关系。方法:应用组织芯片和免疫组织化学Envision法检测71例乳腺癌组织和41例非癌组织中STAT3、磷酸化STAT3、SOCS3的表达情况及其与临床病理参数的关系。结果:(1)在71例乳腺癌中STAT3、磷酸化STAT3和SOCS3的阳性表达率分别为78.9%、69.0%和29.6%,与对照组比较,差异有统计学意义(P<0.01,P<0.01,P<0.05);(2)STAT3、磷酸化STAT3表达与乳腺癌的组织学分级、腋窝淋巴结转移、临床分期呈正相关(P<0.05,P<0.01),与患者年龄、瘤体大小和组织学类型无关(P>0.05);SOCS3表达与乳腺癌组织学分级、腋窝淋巴结转移呈负相关(P<0.05),与患者年龄、组织学类型、瘤体大小和临床分期无关(P>0.05);(3)乳腺癌组织中STAT3、磷酸化STAT3表达与SOCS3表达分别呈负相关(P<0.01)。结论:乳腺癌STAT3、磷酸化STAT3的高表达和SOCS3的缺失表达与肿瘤发生发展、浸润转移密切相关;对其检测有助于判断乳腺癌的恶性程度及生物学行为。 Objective: To investigate the expressions of signal transducer and activators of transcription 3 ( STAT3 ) and suppressor of cytokine signaling 3 (SOCS3) protein in the breast carcinoma tissue and their relationship with tumor differentiation, invasion, and metastasis. Methods: The expression of STAT3 ,phospho-STAT3 and SOCS3 protein were determined by tissue microarray and immunohistochemistry with EnVision system in 71 cases of archival breast carcinoma tissues and 41 cases of tissues. The relationship between their expression and the clinical pathological parameters were analyzed. Results: ( 1 ) The positive rates of STAT3, phospho-STAT3, and SOCS3 was 78.9%, 69.0%, and 29.6%, respectively. The difference was significantly different compared with control (P 〈0.01, P 〈0.01, and P 〈0.05). (2) The expressions of STAT3 and phospho-STAT3 were positively related with the histological grade, the axillary lymph node metastasis, and the clinical stage (P 〈0.01 ), but not related with the age, the tumor size, and the histological grade of breast carcinoma tissues (P 〉 0.05 ). The expression of SOCS3 was negatively related with the histopathologic grade and the axillary lymph node metastasis (P 〈 0.05), but was not related with the age, histological type, the tumor size, and the clinical stage ( P 〉 0.05 ). ( 3 ) The expression of STAT3 and phospho-STAT3 had negative correlation with the expression of SOCS3 in breast carcinoma tissues (P 〈 0.01 ). Conclusion: The overexpressions of STAT3 and phospho-STAT3 and the down-regulated expression of SOCS3 closcly correlated with the tumor carcinogenesis, progression, invasion, and metastasis of breast carcinoma. Detection of their expression is helpful in accessing the malignant degree and the biological behaviors of breast carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2007年第4期298-302,共5页 Tumor
关键词 乳腺肿瘤 转录激活因子3 细胞因子信号转导蛋白抑制因子 免疫组织化学 组织芯片 Breast neoplasms Activating transcription factor 3 Suppressor of cytokine signaling proteins Immunohisto-chemistry Tissue microarray
  • 相关文献

参考文献12

  • 1YOSHIMURA A,OHKUBO T,KIGUCHI T,et al.A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors[J].EMBO J,1995,14(12):2816-2826. 被引量:1
  • 2KONONEN J,BUBENDORF L,KALLIONIEMI A,et al.Tissue microarrays for high throughout molecular profiling of tumor specimens[J].Nature Med,1998,4(7):844 -847. 被引量:1
  • 3HE B,YOU L,UEMATSU K,et al.SOCS3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer[J].Proc Natl Acad Sci USA,2003,100(24):14133-14138. 被引量:1
  • 4GRITSKO T,WILLIAMS A,TURKSON J,et al.Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells[J].Clin Cancer Res,2006,12(1):11-19. 被引量:1
  • 5NIU G,WRIGHT KL,HUANG M,et al.Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis[J].Oncogene,2002,21 (13):2000-2008. 被引量:1
  • 6CATLETT-FALCONE R,LANDOWSKI T H,OSHIRO M M,et al.Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells[J].Immunity,1999,10(1):105-115. 被引量:1
  • 7KONNIKOVA L,KOTECKI M,KRUGER M M,et al.Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells[J].BMC Cancer,2003,3:23-31. 被引量:1
  • 8BERCLAZ G,ALTERMATT H J,ROHRBACH V,et al.EGFR dependent expression of STAT3 (but not STAT1) in breast cancer[J].Int J Oncol,2001,19(6):1155-1160. 被引量:1
  • 9SUTHERLAND K D,LINDEMAN G J,CHOONG D Y,et al.Differential hypermethylation of SOCS genes in ovarian and breast carcinomas[J].Oncogene,2004,23 (46):7726-7733. 被引量:1
  • 10CALVISI D F,LADU S,GORDEN A,et al.Ubiquitous activation of Ras and Jak/stat pathways in human HCC[J].Gastroenterology,2006,130(4):1117-1128. 被引量:1

同被引文献38

  • 1STARR R, WlLLSON T A, VlNEY E M, et al. A family of cytokine-inducible inhibitors of signaling[J]. Nature, 1997, 387(6636): 917-921. 被引量:1
  • 2YOSHIMURA A, OHKUBO T, KIGUCHI T, et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine- phosphorylated interleukin 3 and erythropoietin receptors[J]. EMBO J, 1995, 14(12): 2816-2826. 被引量:1
  • 3HAAN S, WULLER S, KACZOR J, et al. SOCS- mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling[J]. Oncogene, 2009, 28(34): 3069-3080. 被引量:1
  • 4TEFFERI A, THIELE J, VARDIMAN J W, et al. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos[J]. Cancer, 2009, 115(17): 3842-3847. 被引量:1
  • 5HATIRNAZ O, URE U, AR C, et al. The SOCS-1 gene methylation in chronic myeloid leukemia patients[J]. Am J Hematol, 2007, 82(8): 729-730. 被引量:1
  • 6WAILBOCI L W, AHMED C M, MUJTABA M G, et al. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist[J]. J Immunol, 2007, 178(8): 5058-5068. 被引量:1
  • 7ESPERT L, DUSANTER-FOURT I, CHELBI-ALIX M K. Negative regulation of the JAK/STAT: pathway implication in tumorigenesis[J]. Bull Cancer, 2005, 92(10): 845-857. 被引量:1
  • 8WU S J, YAO M, CHOU W C, et al. Clinical implications of SOCS1 methylation in myelodysplastic syndrome[J]. Br J Haematol, 2006, 135(3): 317-323. 被引量:1
  • 9CAPELLO D, DEAMBROGI C, ROSSI D, et al. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders[J]. Br J Haematol, 2008, 141(4): 504-511. 被引量:1
  • 10JOST E, DO O N, DAHL E alterations complement et al. Epigenetic mutation of JAK2 tyrosine kinase in patients with BCR/ABL- negative myeloproliferative disorders[J]. Leukemia, 2007, 21 (3): 505-510. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部